🏦 Columbia Financial (CLBK): 16 Insiders Bought $4.3M. Should Investors Follow?
When sixteen executives—including the CEO, CFO and COO—collectively invest more than $4.3 million immediately after a historic corporate transformation, investors should pay attention. But should they buy? We examine Columbia Financial's insider buying, valuation, interest-rate risks and post-conversion outlook.
🚀 SpaceX (SPCX): A Great Company. A Risky Stock.
SpaceX has revolutionized spaceflight, satellite internet, and now artificial intelligence. But after a historic IPO, a $1.9 trillion valuation, and upcoming insider share unlocks, investors face a timeless question: can an extraordinary company still be an expensive stock?
🛩️ DPC Holdings (NYSE: DPC) IPO Analysis: Why Insiders Bought $75 Million at $33 While the Public Paid $47
DPC Holdings owns one of the aerospace industry's most impressive manufacturing franchises. Yet while insiders invested nearly $75 million, they all paid $33 per share—not the $47 public investors faced after the IPO. Here's why valuation discipline still matters.
🚜 Founders Keep Buying EquipmentShare. Wall Street Sees AI. Bears See A Cash Burn Machine.
EquipmentShare may be more than an equipment rental company. Founder purchases, 38% revenue growth and its T3 software platform suggest a differentiated story, though cash flow and capital intensity remain major concerns.
Reddit’s $1 Billion “Upvote”: The Front Page of the Internet Just Got a Massive Buyback
Reddit’s growth is on fire, margins are real, and a $1B buyback plus a $7.5M insider purchase just lit up the tape. Is RDDT the internet’s next compounding machine—or a premium, high-volatility AI data play? Let’s break it down, FUNanc1al style.
York Space: Insiders Buy, But Give It Some… Space
York Space builds satellites fast and cheap—and insiders are buying. But with losses, high valuation, and heavy DoD dependence, YSS still needs time to prove it deserves a higher orbit.
Insiders Just Bought Shares of New Issue Exzeo Group; Should You Purchase XZO?
Exzeo Group (XZO) insiders bought right after the IPO. Profitable growth, strong margins, and a quirky Insurance-as-a-Service story worth watching.
DoorDash Keeps Delivering — And Not Just Food
DoorDash isn’t just bringing food to your door—it’s bringing deals to Wall Street. From Deliveroo to SevenRooms, DASH is snapping up companies, stacking revenue, and gaining investor love. But can this delivery darling keep up the dash?
Intellia Therapeutics Update: Insider Buys, Institutional Muscle & Phase 3 Momentum
Intellia Therapeutics (NTLA) is up 20%, insiders are buying, ARKK and Baker Bros are holding or adding, and Phase 3 trials are moving faster than expected. Here’s why CRISPR medicine may be ready for prime time — or another plot twist.